Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Prominent Pain Clinic with Leading Physician
January 06 2022 - 2:30PM
Milestone Scientific Inc.
(NYSE:MLSS), a leading developer of computerized
drug delivery instruments, that provide painless and precise
injections, today announced that Dr. Harsh Govil, MD, MPH, whose
practice is based in Statesville, NC, has begun incorporating the
CompuFlo® Epidural instrument into his practice for pain
management, following a successful evaluation. Dr. Govil plans to
utilize the CompuFlo Epidural instrument for office-based
procedures to safely and quickly access the epidural space.
Dr. Govil commented, “I am excited to incorporate Milestone
Scientific’s CompuFlo Epidural instrument into my practice, as I
believe it represents an advancement in pain management. The
instrument provides real-time feedback and confirmation of epidural
placement, which offers a number of advantages in terms of safety
and efficacy.”
Arjan Haverhals, CEO and president of Milestone Scientific,
stated, “We are delighted to announce that another major thought
leader has incorporated the CompuFlo Instrument into his pain
practice at a nationally recognized institution. Dr. Govil is a
true leader and pioneer in the field of pain management. We believe
the use of our technology by Dr. Govil illustrates the commitment
to patient safety, and incorporates the latest technologies to
improve the patient experience. As we have indicated previously, we
are excited to expand beyond labor and delivery, and are pushing
forward into the pain management market addressing the total market
with over 11 million reported epidural procedures each year. We
believe the traction we are gaining bodes well for the business
heading into 2022.”
Dr. Harsh Govil joined Piedmont HealthCare as a non-surgical
spine specialist. After completing residency in physical medicine
and rehabilitation he went to Cleveland Clinic’s world renowned
pain management center for fellowship training in interventional
pain management. During his fellowship he received specialized
training in managing low back and neck pain caused by various
spinal conditions. Dr. Govil offers the latest, most advanced
techniques available for pain management. He is certified by the
American Board of Physical Medicine with subspecialty certification
in pain medicine.
About Milestone Scientific
Inc.Milestone Scientific Inc. (MLSS), a technology focused
medical research and development company that patents, designs and
develops innovative injection technologies and instruments for
medical, dental and cosmetic applications. Milestone Scientific’s
computer-controlled systems are designed to make injections
precise, efficient and increase the overall patient comfort and
safety. Their proprietary DPS Dynamic Pressure Sensing Technology®
instruments is the platform to advance the development of
next-generation devices, regulating flow rate and monitoring
pressure from the tip of the needle, through platform extensions of
subcutaneous drug delivery, including local anesthetic. To learn
more, view the MLSS brand video or
visit milestonescientific.com.
Safe Harbor Statement
This press release contains forward-looking
statements regarding the timing and financial impact of Milestone's
ability to implement its business plan, expected revenues, timing
of regulatory approvals and future success. These statements
involve a number of risks and uncertainties and are based on
assumptions involving judgments with respect to future economic,
competitive and market conditions, future business decisions and
regulatory developments, all of which are difficult or impossible
to predict accurately and many of which are beyond Milestone's
control. Some of the important factors that could cause actual
results to differ materially from those indicated by the
forward-looking statements are general economic conditions, failure
to achieve expected revenue growth, changes in our operating
expenses, adverse patent rulings, FDA or legal developments,
competitive pressures, changes in customer and market requirements
and standards, and the risk factors detailed from time to time in
Milestone's periodic filings with the Securities and Exchange
Commission, including without limitation, Milestone's Annual Report
for the year ended December 31, 2020. The forward-looking
statements in this press release are based upon management's
reasonable belief as of the date hereof. Milestone undertakes no
obligation to revise or update publicly any forward-looking
statements for any reason.
Contact: David Waldman or
Natalya RudmanCrescendo Communications, LLCEmail:
mlss@crescendo-ir.comTel: 212-671-1020
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Apr 2023 to Apr 2024